Overnight urinary excretion of isoflavones as an indicator for dietary isoflavone intake in Korean girls of pubertal age

British Journal of Nutrition

Volumn 104, Issue 5, 2010, Pages 709-715

  Kim, Jihye ^a   Kim, Hye Jin ^b   Joung, Hyojee ^b   Park, Min Kyung ^b   Li, Shanji ^c   Song, Yoonju ^d   Franke, Adrian A ^e   Paik, Hee Young ^b  

^a Daegu University   (South Korea)

^b Seoul National University   (South Korea)

^c JILIN MEDICAL COLLEGE   (China)

^d The Catholic University of Korea   (South Korea)

^e UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Isoflavone intake; Isoflavone metabolites; Overnight urinary excretion; Young Korean girls

Indexed keywords

DAIDZEIN; DIHYDRODAIDZEIN; DIHYDROGENISTEIN; EQUOL; GENISTEIN; GLYCITEIN; ISOFLAVONOID; O DESMETHYLANGOLENSIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; ISOFLAVONE DERIVATIVE;

AGE; ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; DIETARY INTAKE; FEEDING BEHAVIOR; FEMALE; FOOD ANALYSIS; FOOD COMPOSITION; HUMAN; KOREA; PUBERTY; SCHOOL CHILD; SEXUAL MATURATION; URINARY EXCRETION; URINE LEVEL; DIET; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICAL RECORD; METABOLISM; URINE;

BIOLOGICAL MARKERS; CHILD; CHROMATOGRAPHY, LIQUID; DIET; DIET RECORDS; FEMALE; HUMANS; ISOFLAVONES; KOREA; MASS SPECTROMETRY; PUBERTY;

EID: 77956909051     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510000978     Document Type: Article

References (44)

1. Friedman M & Brandon DL (2001) Nutritional and health benefits of soy proteins. J Agric Food Chem 49, 1069-1086.
2. Messina M, Gardner C & Barnes S (2002) Gaining insight into the health effects of soy but a long way still to go: Commentary on the fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease. J Nutr 132, 547S-551S.
3. Stark A & Madar Z (2002) Phytoestrogens: A review of recent findings. J Pediatr Endocrinol Metab 15, 561-572.
4. Rowland I, Faughnan M, Hoey L, et al. (2003) Bioavailability of phyto-oestrogens. Br J Nutr 89, Suppl. 1, S45-S58.
5. Setchell KD, Brown NM, Zimmer-Nechemias L, et al. (2002) Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 76, 447-453.
6. Coldham NG, Darby C, Hows M, et al. (2002) Comparative metabolism of genistin by human and rat gut microflora: Detection and identification of the end-products of metabolism. Xenobiotica 32, 45-62.
7. Joannou GE, Kelly GE, Reeder AY, et al. (1995) A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J Steroid Biochem Mol Biol 54, 167-184.
8. Day AJ, DuPont MS, Ridley S, et al. (1998) Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity. FEBS Lett 436, 71-75.
9. Atkinson C, Skor HE, Fitzgibbons ED, et al. (2002) Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake. Cancer Epidemiol Biomarkers Prev 11, 253-260.
10. Chen Z, Zheng W, Custer LJ, et al. (1999) Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 33, 82-87.
11. Grace PB, Taylor JI, Low YL, et al. (2004) Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition- Norfolk. Cancer Epidemiol Biomarkers Prev 13, 698-708.
12. Maskarinec G, Singh S, Meng L, et al. (1998) Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev 7, 613-619.
13. Seow A, Shi CY, Franke AA, et al. (1998) Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 7, 135-140.
14. Sung CJ (2002) The effect of soy isoflavone supplementation on urinary isoflavone excretion in Korean postmenopausal women. J Korean Soc Food Sci Nutr 31, 1043-1047.
15. Franke AA, Custer LJ & Hundahl SA (2004) Determinants for urinary and plasma isoflavones in humans after soy intake. Nutr Cancer 50, 141-154.
16. Shu XO, Jin F, Dai Q, et al. (2001) Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10, 483-488.
17. Wu AH, Wan P, Hankin J, et al. (2002) Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23, 1491-1496.
18. Thanos J, Cotterchio M, Boucher BA, et al. (2006) Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 17, 1253-1261.
19. Korde LA, Wu AH, Fears T, et al. (2009) Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev 18, 1050-1059.
20. Franke AA, Halm BM, Custer LJ, et al. (2006) Isoflavones in breastfed infants after mothers consume soy. Am J Clin Nutr 84, 406-413.
21. Halm BM, Ashburn LA & Franke AA (2007) Isoflavones from soya foods are more bioavailable in children than adults. Br J Nutr 98, 998-1005.
22. Song Y, Paik HY & Joung H (2008) Soybean and soy isoflavone intake indicate a positive change in bone mineral density for 2 years in young Korean women. Nutr Res 28, 25-30.
23. Park MK, Song Y, Joung H, et al. (2007) Establishment of an isoflavone database for usual Korean foods and evaluation of isoflavone intake among Korean children. Asia Pac J Clin Nutr 16, 129-139.
24. Kimira M, Arai Y, Shimoi K, et al. (1998) Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol 8, 168-175.
25. Liu Z, Li W, Sun J, et al. (2004) Intake of soy foods and soy isoflavones by rural adult women in China. Asia Pac J Clin Nutr 13, 204-209.
26. Mei J, Yeung SS & Kung AW (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86, 5217-5221.
27. Clarke DB & Lloyd AS (2004) Dietary exposure estimates of isoflavones from the 1998 UK Total Diet Study. Food Addit Contam 21, 305-316.
28. Keinan-Boker L, van Der Schouw YT, Grobbee DE, et al. (2004) Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 79, 282-288.
29. Kreijkamp-Kaspers S, Kok L, Bots ML, et al. (2004) Dietary phytoestrogens and vascular function in postmenopausal women: A cross-sectional study. J Hypertens 22, 1381-1388.
30. Maskarinec G, Franke AA, Williams AE, et al. (2004) Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev 13, 1736-1744.
31. Marshall WA & Tanner JM (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44, 291-303.
32. The Korean Nutrition Society (2000) Recommended Dietary Allowances for Koreans. Seoul: Joonang-Munhwa.
33. Blair RM, Appt SE, Franke AA, et al. (2003) Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J Nutr 133, 2262-2267.
34. Franke AA & Custer LJ (1994) High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J Chromatogr B Biomed Appl 662, 47-60.
35. Franke AA, Custer LJ, Wilkens LR, et al. (2002) Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci 777, 45-59.
36. Yamamoto S, Sobue T, Sasaki S, et al. (2001) Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 131, 2741-2747.
37. Ritchie MR, Morton MS, Thompson AM, et al. (2004) Investigation of the reliability of 24 h urine excretion as a biomarker of isoflavone exposure over time and over a wide range of isoflavone intakes. Eur J Clin Nutr 58, 1286-1289.
38. Maskarinec G, Oshiro C, Morimoto Y, et al. (2005) Urinary isoflavone excretion as a compliance measure in a soy intervention among young girls: A pilot study. Eur J Clin Nutr 59, 369-375.
39. Lampe JW, Gustafson DR, Hutchins AM, et al. (1999) Urinary isoflavonoid and lignan excretion on a Western diet: Relation to soy, vegetable, and fruit intake. Cancer Epidemiol Biomarkers Prev 8, 699-707.
40. Ingram D, Sanders K, Kolybaba M, et al. (1997) Case-control study of phyto-oestrogens and breast cancer. Lancet 350, 990-994.
41. Karr SC, Lampe JW, Hutchins AM, et al. (1997) Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am J Clin Nutr 66, 46-51.
42. Xu X, Wang HJ, Murphy PA, et al. (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124, 825-832.
43. Franke AA, Halm BM & Ashburn LA (2008) Isoflavones in children and adults consuming soy. Arch Biochem Biophys 476, 161-170.
44. United States Department of Agriculture & Agriculture Research Service (2002) Documentation for the USDA-IOWA State University isoflavone database. http://www.nal. usda.gov/fnic/foodcomp/Data/isoflav/isoflav.html (accessed October 2004).